CATALOGO DEI PRODOTTI DELLA RICERCA

ZIPETO, Donato
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.593
EU - Europa 10.022
AS - Asia 9.851
SA - Sud America 985
AF - Africa 195
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 7
Totale 31.691
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.354
CN - Cina 4.404
RU - Federazione Russa 3.401
SG - Singapore 3.156
GB - Regno Unito 2.406
IT - Italia 1.151
BR - Brasile 800
VN - Vietnam 796
HK - Hong Kong 621
FR - Francia 586
DE - Germania 526
SE - Svezia 485
IE - Irlanda 475
FI - Finlandia 454
KR - Corea 274
UA - Ucraina 168
CA - Canada 140
IN - India 114
ID - Indonesia 82
NG - Nigeria 76
AR - Argentina 68
NL - Olanda 68
BE - Belgio 64
TR - Turchia 63
MX - Messico 62
JP - Giappone 53
BD - Bangladesh 48
PL - Polonia 44
IQ - Iraq 42
ZA - Sudafrica 41
AU - Australia 36
EC - Ecuador 34
AT - Austria 31
ES - Italia 30
LT - Lituania 27
UZ - Uzbekistan 23
PK - Pakistan 22
JO - Giordania 18
SA - Arabia Saudita 17
RO - Romania 16
CL - Cile 15
CO - Colombia 15
AE - Emirati Arabi Uniti 13
VE - Venezuela 13
IR - Iran 12
MA - Marocco 12
PH - Filippine 12
PY - Paraguay 12
AZ - Azerbaigian 10
CH - Svizzera 10
EG - Egitto 10
KE - Kenya 10
PE - Perù 10
BO - Bolivia 9
CR - Costa Rica 9
IL - Israele 9
TN - Tunisia 9
KZ - Kazakistan 8
NO - Norvegia 8
NP - Nepal 8
SI - Slovenia 8
TG - Togo 8
UY - Uruguay 8
DK - Danimarca 7
LB - Libano 7
HU - Ungheria 6
OM - Oman 6
AL - Albania 5
BG - Bulgaria 5
BJ - Benin 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
ET - Etiopia 5
EU - Europa 5
MY - Malesia 5
SN - Senegal 5
TH - Thailandia 5
BY - Bielorussia 4
GR - Grecia 4
KG - Kirghizistan 4
LV - Lettonia 4
PA - Panama 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
DO - Repubblica Dominicana 3
JM - Giamaica 3
NI - Nicaragua 3
PT - Portogallo 3
SV - El Salvador 3
TW - Taiwan 3
AM - Armenia 2
AO - Angola 2
EE - Estonia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
IS - Islanda 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MK - Macedonia 2
Totale 31.656
Salva come PNG Salva come JPEG
Città #
Southend 2.051
Singapore 1.690
Jacksonville 1.308
Moscow 1.121
Chandler 1.066
San Jose 980
Ashburn 954
Dallas 913
Verona 656
Hong Kong 609
Ann Arbor 481
Dublin 473
Woodbridge 456
Beijing 373
Houston 335
The Dalles 271
Ho Chi Minh City 245
New York 233
Wilmington 193
Lawrence 185
Princeton 185
Nanjing 184
Los Angeles 180
Hanoi 144
Jinan 137
Helsinki 127
Shenyang 115
Council Bluffs 108
Tianjin 98
Buffalo 90
Sindelfingen 90
Munich 89
São Paulo 81
Changsha 77
Dong Ket 74
Abuja 73
Boardman 72
Hebei 72
Milan 71
Orem 67
Nanchang 65
Ningbo 62
Redondo Beach 62
Haikou 61
Seattle 61
Zhengzhou 60
Hangzhou 58
Brussels 56
Jakarta 56
Columbus 53
Santa Clara 52
London 50
Montreal 50
Redmond 45
Da Nang 43
Seoul 43
Taizhou 43
Tokyo 42
Frankfurt am Main 41
Jiaxing 41
Cambridge 40
Guangzhou 40
Lancaster 36
Warsaw 36
Toronto 35
Taiyuan 34
Denver 31
Haiphong 31
Rio de Janeiro 31
Atlanta 30
Chennai 30
Redwood City 30
Johannesburg 28
Lappeenranta 28
San Francisco 26
Stockholm 25
Turku 25
Amsterdam 24
Brooklyn 24
Norwalk 24
Oxford 24
Kent 23
Elora 22
Lanzhou 22
Vienna 22
Basingstoke 21
Chicago 21
Fuzhou 21
Rome 21
Bologna 20
Phoenix 20
Falls Church 19
Mexico City 19
Nuremberg 19
Belo Horizonte 18
Mumbai 18
Poplar 18
San Diego 18
Shanghai 18
Tashkent 18
Totale 18.781
Salva come PNG Salva come JPEG
Nome #
CRISPR/Cas9 mediated knock-out of RUNX2 in melanoma cells 1.324
CRISPR/Cas9 genome editing in melanoma cells: new insight of RUNT domain 1.298
MALAT1 Expression Is Deregulated in miR-34a Knockout Cell Lines 361
HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity 296
New immunogens for the induction of broad spectrum neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) 263
CRISPR/Cas9 as a tool for studying the interactions between viral and cellular proteins 262
Broad spectrum neutralizing monoclonal antibodies against HIV-1 elicited by immunizing with fusion complexes 243
HLA-C presence increases human immunodeficiency type 1 (HIV-1) infectivity by interacting with the envelope glycoprotein gp120/41 238
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes and CD4-independent gp120/41s. 236
Fusion complexes and CD4-independent Env for the induction of broad spectrum neutralizing antibodies against HIV-1 236
Human T-cell leukemia virus HBZ and APH-2 antisense proteins interaction with host factors and their involvement in NF-Kb activation 232
Gα15 in early onset of pancreatic ductal adenocarcinoma 232
Testing the performance of the imputation of MHC region in large datasets when using different reference panels 230
HLA-C increases HIV-1 infectivity by interacting with the envelope glycoprotein gp120 230
Induction of human immunodeficiency virus neutralizing antibodies using fusion complexes 228
HLA-C is necessary for optimal HIV-1 infection of human peripheral blood CD4 lymphocytes 228
Analysis of colorectal cancers for human cytomegalovirus presence 226
5. CRISPR/Cas9 for the Study of the Interactions between Viruses and Host 224
Expression of HIV-1 NDK m9 env gene in eukaryotic cells for the induction of HIV-1 neutralizing antibodies 223
Fusion complexes and CD4-independene Env for the induction of broad spectrum neutralizing antibodies against HIV-1 223
Analisi molecolare delle interazioni fra citomegalovirus umano e leucociti 220
Fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 217
2. CRISPR/Cas9 to study virus-host interactions 214
A CRISPR/Cas9 based approach to study the implication of HTLV regulatory proteins in the NF-κB modulation. 214
Molecular characterization of HIV-1 Nef and ACOT8 interaction: insights from in silico structural predictions and in vitro functional assays 213
A potential role of RUNX2- RUNT domain in modulating the expression of genes involved in bone metastases: an in vitro study with melanoma cells 213
Development of chimeric humanized monoclonal antibodies against HIV-1 211
HIV-1-associated neurocognitive disorders: is HLA-C binding stability to β2-microglobulin a missing piece of the pathogenetic puzzle? 211
P-D9 Human Thioesterase 8 and HIV-1 Nef interaction 210
HLA-C associates with Env and Increases HIV-1 infectivity 209
HLA-C increases human immunodeficiency type 1 (HIV-1) infectivity by interacting with the envelope glycoprotein gp120/41. 208
In silico structural prediction and in vitro functional validation to identify the ACOT8 regions involved in the interaction with HIV-1 Nef 207
HTLV-1 and HTLV-2 Tax, HBZ and APH-2 interaction with host factors: their involvement in cellular pathways regulation. 204
CRISPR/Cas9 as a tool for the study of the interactions between viruses and host 204
Presence and role of HLA-C in HIV-1 infection 203
Expression of HIV-1 NDK m7 and m9 env genes in eukaryotic cells for the induction of HIV-1 neutralizing antibodies 201
HLA-C associates with Env and increases HIV-1 infectivity 201
The human T-cell leukemia virus -2 (HTLV-2) antisense protein APH-2 interacts with p65 and inhibits NF-ĸB Tax-2 activation. 200
Expression of a candidate vaccine for AIDS prevention in transgenic tobacco plants 199
Studiare la regione HLA negli esomi 199
Il ruolo di HLA-C nell'infezione da HIV-1 197
Runx2 stimulates neoangiogenesis through the Runt domain in melanoma 197
HLA-C expression levels and binding stability to β2m are involved in HIV-1 infectivity 196
Detection and typing of Human Cytomegalovirus DNA in colorectal cancer 194
Demonstration of the role of HLA-C in HIV-1 infection by siRNA silencing 194
Host-virus interactions: HTLV antisense regulatory proteins play a role in the dysregulation of NF-κB pathway 194
The Runt domain of RUNX2 induces the migration of melanoma cells to bone 193
Stability and expression levels of HLA-C on the cell membrane modulate HIV-1 infectivity 192
Influenza - Prous Science Integrity 189
Association analysis between HIV-1 Env and HLAC using bimolecular fluorescence complementation 189
Association Analysis Between HIV-1 Env and HLA-C Using Bimolecular Fluorescence Complementation 188
Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS 185
Fusion complexes as immunogens for the induction of broad spectrum neutralizing antibodies against HIV-1 185
Dissection of HLA-C gene region to investigate its association with complex traits 184
HTLV ANTISENSE PROTEINS ROLE IN THE NF-κB MODULATION. 183
New Insights into the Runt Domain of RUNX2 in Melanoma Cell Proliferation and Migration 182
Induction of HIV-1 neutralizing antibodies by fusion complexes 180
Advanced cellular models for rare disease study: exploring neural, muscle and skeletal organoids 178
Production of a candidate HIV-1 vaccine in transgenic tobacco plants 176
Unsung hero Robert C. Gallo 176
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 175
HIV-1 Env glycoprotein and HLA-C associate and increase HIV-1 infectivity 175
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 175
Fusion efficiency between the HIV-1 envelope and the target cell membrane is enhanced by the presence of HLA-C molecules 174
Expression and purification of recombinant HTLV-2 Tax protein in mammalian cells 173
Physical activity prevents cartilage degradation: a metabolomics study pinpoints the involvement of vitamin B6 172
HLA-C and HIV-1: a matter of stability 171
Broad spectrum neutralizing antibodies against HIV-1 elicited by immunizing with fusion complexes 170
Induction of human immunodeficiency virus (HIV) neutralizing antibodies with fusion complexes 168
NF-κB activation mediated by HTLV-1 transactivator Tax protein is impaired in TRAF3 knock-out cells. 168
New vaccine strategies for chronic viral infections 168
Benzodiazepine use and HIV-associated neurocognitive impairment: which comes first? 167
Vectors derived from antibodies for transfecting substances into cells 166
HLA-C increases fusion efficiency between the HIV-1 envelope and the cell membrane and is part of the fusion complex 166
Vectors derived from antibodies for transferring substances into cells 164
HTLV deregulation of the NF-κB pathway: an update on tax and antisense proteins role 163
HLA-C stability and AIDS progression 163
HTLV-1 BASIC LEUCIN ZIPPER FACTOR AND ITS HOMOLOGOUS APH-2 IMPAIR NF-κB ACTIVATION MEDIATED BY THE VIRAL ONCOPROTEIN TAX. 162
TRAF3 involvement in the NF-κB pathway deregulation mediated by HTLV-1 Tax protein 159
CRISPR/Cas system: an emerging technology in stem cell research 159
Involvement of HLA-C binding stability to β2-microglobulin in HIV-1 infection 159
Delayed progression to AIDS in HTLV-I/HIV-1 coinfected intravenous drug users 158
Correction for Parolini et al., "Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity" 158
HLA-C increases HIV-1 infectivity and is associated with gp120 157
Expression and purification of recombinant HTLV-II Tax protein in E.Coli and mammalian cells 155
Gelsolin activity controls efficient early HIV-1 infection 154
Cell-based vaccination: rationale for the use of cells co-expressing HIV anv gp120 and HLA class I Cw4 molecules for the induction of neutralizing antibodies 153
A fast and reliable method for detecting SNP rs67384697 (Hsa-miR-148a binding site) by a single run of allele-specific real-time PCR 153
ACE2/ADAM17/TMPRSS2 interplay may be the main risk factor for COVID-19 151
Interferon gamma inducible protein 16 (IFI16) expression is reduced in mantle cell lymphoma 149
TRAF3 Is Required for NF-κB Pathway Activation Mediated by HTLV Tax Proteins 148
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals 147
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 146
Fusion complexes and CD4-independent gp120s for the induction of HIV-1 neutralizing antibodies 145
Fusion complexes and CD4-independent gp120s for the induction of broad spectrum anti HIV-1 neutralizing antibodies 145
Single-chain antibody fragments for transferring substance 141
A simple method for human cytomegalovirus (HCMV) DNA quantitation in clinical samples 140
Increased prevalence of unstable HLA-C variants in HIV-1 rapid-progressor patients 139
Quantificazione del DNA di citomegalovirus umano (HCMV) nei leucociti di pazienti immunocompromessi mediante polymerase chain reaction 139
Induction of human immunodeficiency virus (HIV) broad spectrum neutralizing antibodies with fusion complexes. 138
Totale 21.276
Salva come PNG Salva come JPEG
Categoria #
all - tutte 93.270
article - articoli 39.609
book - libri 4.168
conference - conferenze 46.915
curatela - curatele 0
other - altro 0
patent - brevetti 1.154
selected - selezionate 0
volume - volumi 1.424
Totale 186.540
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021345 0 0 0 0 0 0 0 0 0 16 197 132
2021/20221.498 155 338 16 77 47 48 48 99 54 67 146 403
2022/20233.232 253 312 304 571 288 755 27 196 363 40 75 48
2023/20243.664 66 145 153 180 189 2.278 114 96 19 73 201 150
2024/20254.121 268 264 140 623 174 87 297 210 659 283 272 844
2025/202611.888 811 617 971 1.922 2.918 897 1.248 681 1.021 802 0 0
Totale 31.910